Evidence map›Paper›PMID 36114445›Full record

ArticleBMC bioinformatics2022

Atlas of regulated target genes of transcription factors (ART-TF) in human ES cells.

Alexei A Sharov, Yuhki Nakatake, Weidong Wang

Open access · goldAbstract read
In one paragraph

Article in BMC bioinformatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

Alexei A SharovLaboratory of Genetics and Genomics, National Institute on Aging, National Institutes of Health, Baltimore, MD, 21224-6825, USA. sharov@comcast.net.
Yuhki NakatakeDepartment of Systems Medicine, Mitsunada Sakaguchi Laboratory, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.
Weidong WangLaboratory of Genetics and Genomics, National Institute on Aging, National Institutes of Health, Baltimore, MD, 21224-6825, USA. wangw@grc.nia.nih.gov.
Keio University · JPNational Institute on Aging · USNational Institutes of Health · US

Funding

ISOLATION OF PROTEIN COMPLEX INVOLVED IN BLOOM SYNDROMEZ01AG000657 · NIA · NATIONAL INSTITUTE ON AGING · PI WANG, WEIDONG · 2000 to 2008
$636k
NIA NIH HHS Z01 AG000657-08
6 · The paper itself

Abstract

backgroundTranscription factors (TFs) play central roles in maintaining "stemness" of embryonic stem (ES) cells and their differentiation into several hundreds of adult cell types. The regulatory competence of TFs is routinely assessed by detecting target genes to which they bind. However, these data do not indicate which target genes are activated, repressed, or not affected by the change of TF abundance. There is a lack of large-scale studies that compare the genome binding of TFs with the expression change of target genes after manipulation of each TF.

resultsIn this paper we associated human TFs with their target genes by two criteria: binding to genes, evaluated from published ChIP-seq data (n = 1868); and change of target gene expression shortly after induction of each TF in human ES cells. Lists of direction- and strength-specific regulated target genes are generated for 311 TFs (out of 351 TFs tested) with expected proportion of false positives less than or equal to 0.30, including 63 new TFs not present in four existing databases of target genes. Our lists of direction-specific targets for 152 TFs (80.0%) are larger that in the TRRUST database. In average, 30.9% of genes that respond greater than or equal to twofold to the induction of TFs are regulated targets. Regulated target genes indicate that the majority of TFs are either strong activators or strong repressors, whereas sets of genes that responded greater than or equal to twofold to the induction of TFs did not show strong asymmetry in the direction of expression change. The majority of human TFs (82.1%) regulated their target genes primarily via binding to enhancers. Repression of target genes is more often mediated by promoter-binding than activation of target genes. Enhancer-promoter loops are more abundant among strong activator and repressor TFs.

conclusionsWe developed an atlas of regulated targets of TFs (ART-TF) in human ES cells by combining data on TF binding with data on gene expression change after manipulation of individual TFs. Sets of regulated gene targets were identified with a controlled rate of false positives. This approach contributes to the understanding of biological functions of TFs and organization of gene regulatory networks. This atlas should be a valuable resource for ES cell-based regenerative medicine studies.

Indexed as

Human Embryonic Stem CellsAdultChromatin Immunoprecipitation SequencingEmbryonic Stem CellsGene Regulatory NetworksHumansTranscription FactorsTranscription FactorsEmbryonic stem cellsEnhancer-promoter loopGenome binding of transcription factorsInduction of transcription factorsParametric analysis of gene expressionRegulated target genes

Identifiers

PMID36114445
PMCPMC9479252
OpenAlexW4296164139

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.